(Q34253101)

31 July 2017

0 references

Effect of magnesium supplementation on blood pressure: a meta-analysis (English)

1 reference

31 July 2017

0 references

0 references

L Carpenter

3

0 references

author name string

L Kass

series ordinal

1

1 reference

PubMed ID

22318649

31 July 2017

J Weekes

series ordinal

2

1 reference

31 July 2017

8 February 2012

1 reference

European Journal of Clinical Nutrition

31 July 2017

1 reference

31 July 2017

66

1 reference

31 July 2017

4

1 reference

31 July 2017

411-418

1 reference

https://scigraph.springernature.com/pub.10.1038/ejcn.2012.4

31 July 2017

0 references

cites work

Global burden of blood-pressure-related disease, 2001.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

21 January 2018

Magnesium and exercise

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Distribution of the standardized mean change effect size for meta-analysis on repeated measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Long-term magnesium supplementation in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Exercise and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Magnesium supplementation for the management of primary hypertension in adults

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

The effect of magnesium supplementation on biochemical markers of bone metabolism or blood pressure in healthy young adult females

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.4

7 January 2021

Identifiers

DOI

10.1038/EJCN.2012.4

1 reference

PubMed ID

22318649

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

22318649